Refine
Year of publication
Document Type
- Preprint (611)
- Article (435)
- Conference Proceeding (1)
- Report (1)
- Working Paper (1)
Has Fulltext
- yes (1049)
Is part of the Bibliography
- no (1049)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron scattering (experiments) (11)
- Hadron-Hadron Scattering (8)
- Heavy-ion collision (5)
- Collective Flow (4)
- Quark-Gluon Plasma (4)
- Jets (3)
- Jets and Jet Substructure (3)
- (surface) partial differential equations (2)
- 3D spatio-temporal resolved mathematical models (2)
- Atmospheric chemistry (2)
- COVID-19 (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Finite Volumes (2)
- Germany (2)
- Heavy Quark Production (2)
- Immunotherapy (2)
- LHC (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Non-small cell lung cancer (2)
- Oncology (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Quarkonium (2)
- acute myeloid leukemia (2)
- computational virology (2)
- immunotherapy (2)
- massively parallel multigrid solvers (2)
- realistic geometries (2)
- viral dynamics (2)
- within-host viral modelling (2)
- 140Ce (1)
- 900 GeV (1)
- ACURATE neo (1)
- AIS (1)
- ALICE (1)
- ALICE detector (1)
- APRI (1)
- ASCT (1)
- Accelerators & Beams (1)
- Acute myeloid leukemia (1)
- Adherens junctions (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Anti-nuclei (1)
- Antibody therapy (1)
- Artificial Intelligence (1)
- Atomic and Molecular Physics (1)
- Atomic, Molecular & Optical (1)
- BCOR (1)
- BCORL1 (1)
- BI1361849 (1)
- Bamlanivimab (1)
- Biodiversity Data (1)
- Biogeochemistry (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bladder cancer (1)
- Blood-brain barrier (1)
- Bloodstream infection (1)
- Bloodstream infections (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain tumor (1)
- Burkholderia arboris (1)
- CD36 (1)
- CHIP (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CTLA-4 (1)
- CV9202 (1)
- CVID (1)
- Cancer (1)
- Cancer genomics (1)
- Casirivimab (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Checkpoint inhibitor (1)
- Clinical Trials and Observations (1)
- Clinical trial (1)
- Cluster (1)
- Cohort studies (1)
- Collective Flow, (1)
- Conservation (1)
- Correlative electron and light microscopy (1)
- DBS (1)
- DSS /AOM (1)
- Diagnostic markers (1)
- Digitization (1)
- Electromagnetic transitions (1)
- Electron tomography (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Entomology (1)
- Epidemiology (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus resistance (1)
- Evidence-based guidelines (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extended donor criteria (1)
- FDG-PET/CT (1)
- FIB-4 (1)
- Fibre/foam sandwich radiator (1)
- Freshwater ecology (1)
- GdIr2Si2 (1)
- German PID-NET registry (1)
- Glioma (1)
- Graft function (1)
- Graft survival (1)
- Gram negative bacteria (1)
- HBV (1)
- HDAC-inhibition (1)
- HNSCC (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Head neck cancer (1)
- Heavy Ion Experiment (1)
- Hematology (1)
- Hematopoietic stem cell transplantation (1)
- Herbaria (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IL -17 (1)
- IL -23 (1)
- IL 23p19 knockout mouse (1)
- ISS (1)
- IgG substitution therapy (1)
- Imdevimab (1)
- Immunomonitoring (1)
- Incidence (1)
- Induction therapy (1)
- Intensive care units (1)
- Invariant Mass Distribution (1)
- Invasive species (1)
- Ionisation energy loss (1)
- Isoflurane (1)
- Jet Physics (1)
- Jet Substructure (1)
- Lesion (1)
- Liver transplantation (1)
- Locally advanced (1)
- Long term output (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MACS (1)
- MRI (1)
- Magnetic resonance imaging (MRI) (1)
- Marginal grafts (1)
- Material budget (1)
- Mechanisms of disease (1)
- Minimum Bias (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular matched therapy (1)
- Molecular medicine (1)
- Molecular profiling (1)
- Monte Carlo (1)
- Mott transition (1)
- Multi-Parton Interactions (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myeloid Neoplasia (1)
- NMR spectroscopy (1)
- NSCLC (1)
- Neural network (1)
- Neutron physics (1)
- Neutropenia (1)
- Nivolumab (1)
- Nuclear reactions (1)
- Organ rinse (1)
- Organ shortage (1)
- Osteoporosis (1)
- P2X7 receptor (1)
- PD-1 (1)
- PD-1 inhibitor (1)
- PDEs (1)
- PID prevalence (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb collisions (1)
- Phylogenomics (1)
- Pneumonia (1)
- Poecilia mexicana (1)
- Polarization (1)
- Population genetics (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Psoriasis vulgaris (1)
- QCD (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- RNA (1)
- RNA decay (1)
- Radiation detectors (1)
- Radiative capture (1)
- Radical cystectomy (1)
- Radiotherapy (1)
- Rapidity Range (1)
- Registries (1)
- Relativistic heavy-ion collisions (1)
- Renal cell carcinoma (1)
- Research Infrastructure (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- SMAD (1)
- Semantics (1)
- Sexual selection (1)
- Status epilepticus (1)
- Stenotrophomonas maltophilia (1)
- Stentoplasty (1)
- Systematic Uncertainty (1)
- T cell/histiocyte rich large B cell lymphoma (1)
- TAVR (1)
- TGFβ (1)
- TR (1)
- Tacrolimus (1)
- Targeted therapy (1)
- Taxonomy (1)
- Thermodynamics (1)
- Thoracic trauma (1)
- Thrombotic microangiopathy (1)
- Thrombotic thrombocytopenic purpura (1)
- Time Projection Chamber (1)
- TmRh2Si2 (1)
- Tracking (1)
- Transition radiation detector (1)
- Transitional cell carcinoma (1)
- Transverse momentum (1)
- Treatment (1)
- Trigger (1)
- Tumor growth (1)
- Urothelial cancer (1)
- VIM (1)
- Vector Boson Production (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Viral load (1)
- X-ray crystallography (1)
- X-ray irradiation (1)
- Xenon-based gas mixture (1)
- acoustic radiation force impulse imaging (1)
- adaptation (1)
- advanced melanoma (1)
- adversity (1)
- age (1)
- allostasis (1)
- anti-epileptic drug (1)
- aortic stenosis (1)
- autologous stem cell transplantation (1)
- biomarker (1)
- blood cell mutations (1)
- brain metastases (1)
- brain metastasis (1)
- brain shift (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- calcium dynamics (1)
- calcium-independent phospholipase A2β (1)
- capture (1)
- cdk2/cyclin A (1)
- cerebral pseudoprogression (1)
- cerium (1)
- chemoconvulsant (1)
- chemotherapy (1)
- chronic colitis (1)
- clonal dominance (1)
- clonal haematopoiesis (1)
- clonal hematopoiesis (1)
- clonal transfer (1)
- colon cancer (1)
- community assembly (1)
- complete response (1)
- complex systems (1)
- coping (1)
- correlated electrons (1)
- cross-section (1)
- cytarabine dose (1)
- dE/dx (1)
- detailed modeling (1)
- detector (1)
- diffuse large B cell lymphoma (1)
- discontinuation (1)
- discontinuous dose dependency (1)
- disease outbreaks (1)
- disease progression (1)
- disorder (1)
- distributed computation (1)
- dynamic system (1)
- ectosomes (1)
- elderly (1)
- electrical stimulation (1)
- electrophoresis (1)
- epileptogenesis (1)
- essential tremor (1)
- everolimus (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- female choice (1)
- fibrotest (1)
- flux growth (1)
- gel (1)
- gene expression profiling (1)
- gene signature (1)
- generalized additive model (1)
- genome (1)
- glioblastoma (1)
- guidelines (1)
- head and neck squamous cell carcinoma (1)
- healthcare systems (1)
- heart failure (1)
- heavy ion experiments (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- hepatitis C virus (1)
- hepatitis C virus (HCV) (1)
- hippocampal sclerosis (1)
- homeostasis (1)
- host response (1)
- hybrid (1)
- hypoxia (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitors (1)
- immune checkpoint inhibitors (ICI) (1)
- immune modulation (1)
- immune related adverse events (irAE) (1)
- infections (1)
- inflammasome (1)
- inflammation (1)
- information storage (1)
- inpatient hospital admissions (1)
- interleukin-1β (1)
- leukemia (1)
- liver metastasis (1)
- local information dynamics (1)
- lockdown (1)
- loss-of-function (1)
- low-dose radiation therapy (1)
- lung cancer (1)
- mRNA active cancer immunotherapy (1)
- magnetism (1)
- mathematical models of viral RNA cycle (1)
- medical device (1)
- medical informatics initiative (1)
- mental health (1)
- metastatic renal cell carcinoma (1)
- microbial colonization (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mouthwash (1)
- mouthwash solution (1)
- n_TOF (1)
- neoadjuvant immunochemotherapy (1)
- neural dynamics (1)
- neurological complication (1)
- neurological side effects (1)
- neuron (1)
- neutron (1)
- nodular lymphocyte predominant Hodgkin lymphoma (1)
- non-independent mate choice (1)
- non-invasive fibrosis assessment (1)
- noncoding RNA (1)
- ntracellular signaling (1)
- nucleosynthesis (1)
- organic conductor (1)
- outbreak (1)
- p+p collisions (1)
- p47phox (1)
- pandemic (1)
- parallel (1)
- parameter estimation (1)
- patterns of progression (1)
- pembrolizumab (1)
- perioperative ischemia (1)
- phase IV (1)
- point shear wave elastography (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- predator recognition (1)
- predictive coding (1)
- pressure (1)
- primary immunodeficiency (PID) (1)
- propensity score matching (1)
- pulsed-field (1)
- quark gluon plasma (1)
- registry for primary immunodeficiency (1)
- reproducibility (1)
- rigor (1)
- risk stratification (1)
- s-process (1)
- second-line (1)
- second-line immunotherapy (1)
- soil bacteria communities (1)
- somatic mutations (1)
- spatio-temporal analysis (1)
- standardization (1)
- status epilepticus (1)
- stereotactic radiosurgery (1)
- stress (1)
- survival (1)
- targeted therapy (1)
- temporal lobe epilepsy (1)
- transcatheter aortic valve replacement (1)
- transfemoral (1)
- transient elastography (1)
- treatment resistance (1)
- tumor microenvironment (1)
- university hospitals (1)
- uveal melanoma (1)
- variable selection (1)
- ventralis intermedius nucleus (1)
- visual system (1)
- voltage sensitive dye imaging (1)
Institute
- Physik (955)
- Frankfurt Institute for Advanced Studies (FIAS) (853)
- Informatik (822)
- Medizin (66)
- Geowissenschaften (9)
- Biowissenschaften (5)
- ELEMENTS (3)
- Informatik und Mathematik (3)
- Institut für Ökologie, Evolution und Diversität (3)
- Biochemie und Chemie (2)
Long-range angular correlations on the near and away side in p–Pb collisions at √sNN=5.02 TeV
(2013)
Angular correlations between charged trigger and associated particles are measured by the ALICE detector in p–Pb collisions at a nucleon–nucleon centre-of-mass energy of 5.02 TeV for transverse momentum ranges within 0.5<pT,assoc<pT,trig<4 GeV/c. The correlations are measured over two units of pseudorapidity and full azimuthal angle in different intervals of event multiplicity, and expressed as associated yield per trigger particle. Two long-range ridge-like structures, one on the near side and one on the away side, are observed when the per-trigger yield obtained in low-multiplicity events is subtracted from the one in high-multiplicity events. The excess on the near-side is qualitatively similar to that recently reported by the CMS Collaboration, while the excess on the away-side is reported for the first time. The two-ridge structure projected onto azimuthal angle is quantified with the second and third Fourier coefficients as well as by near-side and away-side yields and widths. The yields on the near side and on the away side are equal within the uncertainties for all studied event multiplicity and pT bins, and the widths show no significant evolution with event multiplicity or pT. These findings suggest that the near-side ridge is accompanied by an essentially identical away-side ridge.
The ALICE collaboration at the LHC reports measurement of the inclusive production cross section of electrons from semi-leptonic decays of beauty hadrons with rapidity |y|<0.8 and transverse momentum 1<pT<10 GeV/c, in pp collisions at s√= 2.76 TeV. Electrons not originating from semi-electronic decay of beauty hadrons are suppressed using the impact parameter of the corresponding tracks. The production cross section of beauty decay electrons is compared to the result obtained with an alternative method which uses the distribution of the azimuthal angle between heavy-flavour decay electrons and charged hadrons. Perturbative QCD calculations agree with the measured cross section within the experimental and theoretical uncertainties. The integrated visible cross section, σb→e=3.47±0.40(stat)+1.12−1.33(sys)±0.07(norm)μb, was extrapolated to full phase space using Fixed Order plus Next-to-Leading Log (FONLL) predictions to obtain the total bb¯ production cross section, σbb¯=130±15.1(stat)+42.1−49.8(sys)+3.4−3.1(extr)±2.5(norm)±4.4(BR)μb.
The ALICE collaboration at the LHC reports measurement of the inclusive production cross section of electrons from semi-leptonic decays of beauty hadrons with rapidity |y|<0.8 and transverse momentum 1<pT<10 GeV/c, in pp collisions at s√= 2.76 TeV. Electrons not originating from semi-electronic decay of beauty hadrons are suppressed using the impact parameter of the corresponding tracks. The production cross section of beauty decay electrons is compared to the result obtained with an alternative method which uses the distribution of the azimuthal angle between heavy-flavour decay electrons and charged hadrons. Perturbative QCD calculations agree with the measured cross section within the experimental and theoretical uncertainties. The integrated visible cross section, σb→e=3.47±0.40(stat)+1.12−1.33(sys)±0.07(norm)μb, was extrapolated to full phase space using Fixed Order plus Next-to-Leading Log (FONLL) predictions to obtain the total bb¯ production cross section, σbb¯=130±15.1(stat)+42.1−49.8(sys)+3.4−3.1(extr)±2.5(norm)±4.4(BR)μb.
Transverse momentum spectra of π±, K± and p(p¯) up to pT = 20 GeV/c at mid-rapidity in pp and Pb-Pb collisions at sNN−−−√= 2.76 TeV have been measured using the ALICE detector at the Large Hadron Collider. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3GeV/c in central Pb-Pb collisions. Below the peak, pT < 3 GeV/c, both ratios are in good agreement with hydrodynamical calculations, suggesting that the peak itself is dominantly the result of radial flow rather than anomalous hadronization processes. For pT > 10 GeV/c particle ratios in pp and Pb-Pb collisions are in agreement and the nuclear modification factors for π±, K± and p(p¯) indicate that, within the systematic and statistical uncertainties, the suppression is the same. This suggests that the chemical composition of leading particles from jets in the medium is similar to that of vacuum jets.
The pT-differential production cross section of electrons from semileptonic decays of heavy-flavor hadrons has been measured at mid-rapidity in proton-proton collisions at s√=2.76 TeV in the transverse momentum range 0.5 < pT < 12 GeV/c with the ALICE detector at the LHC. The analysis was performed using minimum bias events and events triggered by the electromagnetic calorimeter. Predictions from perturbative QCD calculations agree with the data within the theoretical and experimental uncertainties.
The pT-differential production cross section of electrons from semileptonic decays of heavy-flavor hadrons has been measured at mid-rapidity in proton-proton collisions at s√=2.76 TeV in the transverse momentum range 0.5 < pT < 12 GeV/c with the ALICE detector at the LHC. The analysis was performed using minimum bias events and events triggered by the electromagnetic calorimeter. Predictions from perturbative QCD calculations agree with the data within the theoretical and experimental uncertainties.
The inclusive charged particle transverse momentum distribution is measured in proton–proton collisions at s=900 GeV at the LHC using the ALICE detector. The measurement is performed in the central pseudorapidity region (|η|<0.8) over the transverse momentum range 0.15<pT<10 GeV/c. The correlation between transverse momentum and particle multiplicity is also studied. Results are presented for inelastic (INEL) and non-single-diffractive (NSD) events. The average transverse momentum for |η|<0.8 is 〈pT〉INEL=0.483±0.001 (stat.)±0.007 (syst.) GeV/c and 〈pT〉NSD=0.489±0.001 (stat.)±0.007 (syst.) GeV/c, respectively. The data exhibit a slightly larger 〈pT〉 than measurements in wider pseudorapidity intervals. The results are compared to simulations with the Monte Carlo event generators PYTHIA and PHOJET.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
We present the first measurement of the proton–Ω correlation function in heavy-ion collisions for the central (0–40%) and peripheral (40–80%) Au + Au collisions at √sNN = 200 GeV by the STAR experiment at the Relativistic Heavy-Ion Collider (RHIC). Predictions for the ratio of peripheral collisions to central collisions for the proton–Ω correlation function are sensitive to the presence of a nucleon– bound state. These predictions are based on the proton– interaction extracted from (2 + 1)-flavor lattice QCD calculations at the physical point. The measured ratio of the proton–Ω correlation function between the peripheral (small system) and central (large system) collisions is less than unity for relative momentum smaller than 40 MeV/c. Comparison of our measured correlation ratio with theoretical calculation slightly favors a proton– bound system with a binding energy of ∼ 27 MeV.
We present a measurement of inclusive J /ψ production at mid-rapidity (|y| < 1) in p+p collisions at a center-of-mass energy of √s = 200 GeV with the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The differential production cross section for J /ψ as a function of transverse momentum (p T ) for 0 < p T < 14 GeV/c and the total cross section are reported and compared to calculations from the color evaporation model and the non-relativistic Quantum Chromodynamics model. The dependence of J /ψ relative yields in three p T intervals on charged-particle multiplicity at mid-rapidity is measured for the first time in p+p collisions at √s = 200 GeV and compared with that measured at √s = 7 TeV, PYTHIA8 and EPOS3 Monte Carlo generators, and the Percolation model prediction.